Cardiac

Stem cell therapy is being tested for a variety of cardiac conditions, ranging from congenital defects in newborns to heart failure in adults. The use of cord blood to support heart surgery on newborns has been developed in Ukraine, and the first patient Ilya is more than ten years old.